We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AZILECT (Teva Pharma Australia Pty Ltd)
Product name
AZILECT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
135 working days (255)
Active ingredients
rasagiline
Registration type
EOI
Indication
AZILECT-RASAGILINE is now also indicated as adjunct therapy to dopamine agonist or to levodovap.